Iradimed (IRMD) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16% |
| Dec 31, 2025 | -5.18% |
| Sep 30, 2025 | 7.77% |
| Jun 30, 2025 | 4.64% |
| Mar 31, 2025 | 3.46% |
| Dec 31, 2024 | 4.33% |
| Sep 30, 2024 | 4.78% |
| Jun 30, 2024 | 2.20% |
| Mar 31, 2024 | -4.49% |
| Dec 31, 2023 | 5.43% |
| Sep 30, 2023 | 7.34% |
| Jun 30, 2023 | 7.68% |
| Mar 31, 2023 | -11.57% |
| Dec 31, 2022 | 7.50% |
| Sep 30, 2022 | 5.05% |
| Jun 30, 2022 | 4.60% |
| Mar 31, 2022 | -12.65% |
| Dec 31, 2021 | 5.72% |
| Sep 30, 2021 | 3.73% |
| Jun 30, 2021 | 4.70% |
| Mar 31, 2021 | 1.58% |
| Dec 31, 2020 | 0.91% |
| Sep 30, 2020 | 2.33% |
| Jun 30, 2020 | 0.67% |
| Mar 31, 2020 | 2.46% |
| Dec 31, 2019 | 6.64% |
| Sep 30, 2019 | 10.07% |
| Jun 30, 2019 | 4.47% |
| Mar 31, 2019 | 12.33% |
| Dec 31, 2018 | 3.48% |
| Sep 30, 2018 | 9.29% |
| Jun 30, 2018 | 6.39% |
| Mar 31, 2018 | 3.20% |
| Dec 31, 2017 | 2.88% |
| Sep 30, 2017 | 2.92% |
| Jun 30, 2017 | -1.53% |
| Mar 31, 2017 | 0.60% |
| Dec 31, 2016 | 4.81% |
| Sep 30, 2016 | 9.71% |
| Jun 30, 2016 | -3.30% |
| Mar 31, 2016 | -5.09% |
| Dec 31, 2015 | 13.51% |
| Sep 30, 2015 | 7.96% |
| Jun 30, 2015 | 10.57% |
| Mar 31, 2015 | 11.59% |
| Dec 31, 2014 | 4.01% |
| Sep 30, 2014 | 125.55% |